CBD’s Alcohol-Intake Findings in Mice Varied With Both Sex and Dose
In mouse binge-drinking experiments summarized in the review, lower repeated CBD doses reduced intake in males, while a higher dose reduced intake in both sexes. The findings did not support a simple claim that females were unresponsive.
The experiment used a defined drinking model
The review describes male and female C57BL/6J mice tested with the drinking-in-the-dark procedure. Repeated CBD at 15, 30 or 60 mg/kg reduced ethanol intake only in males. A higher tested dose of 90 mg/kg reduced intake under acute and repeated schedules in both males and females.
The comparison included an exposure dimension
A sex-related difference at one part of the tested dose range does not establish an absolute difference across all doses. The higher-dose finding qualifies such an interpretation. Conversely, a response in both groups at the higher dose does not show identical effect sizes, pharmacokinetics or tolerability. The supplied summary does not justify inventing those comparisons.
These were animal consumption findings
The injected doses and experimental access schedule do not provide a human CBD regimen for alcohol-use disorder. Changes in selected gene-expression measures accompanied some responses, but their association does not establish that they fully caused the intake change. A useful account preserves both sex and dose, identifies the drinking model and limits the conclusion to the measured behavior. It supplies a research question about response variation rather than a rule for treating men and women differently.
Related analysis: the broader review findings and limitations.
Research cited
This analysis draws on the supplied review. Individual studies are discussed as summarized there: Navarrete and colleagues (2021). Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.
